首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備拋棄式

預填充式注射器市場規模、佔有率和成長分析（按類型、材質、應用、通路和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1902917

預填充式注射器市場規模、佔有率和成長分析（按類型、材質、應用、通路和地區分類）－2026-2033年產業預測

Prefilled Syringes Market Size, Share, and Growth Analysis, By Type (Disposable, Reusable), By Material (Glass, Plastic), By Application, By Distribution Channel, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 274 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球預填充式注射器市場規模預計在 2024 年達到 75.2 億美元，從 2025 年的 83.2 億美元成長到 2033 年的 186.2 億美元，在預測期（2026-2033 年）內複合年成長率為 10.6%。

隨著製藥業尋求高效便捷的給藥解決方案，全球預填充式注射器市場正經歷快速成長。隨著人們對自我護理的日益關注，預填充式注射器的便利性和易用性預計將顯著提升市場需求，尤其是在避孕藥和慢性病管理方面。糖尿病和關節炎盛行率的不斷上升，以及生物相似藥的推廣，進一步推動了已開發市場的發展動能。此外，氣喘等疾病的高發生率也凸顯了人們對便利治療方案的需求。隨著醫療保健消費者越來越重視自我給藥和安全性，預填充式注射器預計將在給藥領域佔據越來越大的市場佔有率。

推動全球預填充式注射器市場發展的因素

糖尿病和類風濕性關節炎等慢性疾病的增加顯著提高了疫苗的需求，而疫苗主要透過注射給藥。注射液需求的激增直接促進了預填充式注射器的普及。這些注射器具有多項優勢，例如透過可控包裝來提高安全性，降低污染風險並最大限度地減少劑量誤差，使其成為疫苗和治療藥物給藥的首選。因此，對高效給藥系統的日益依賴正在推動預填充式注射器市場的擴張。

全球預填充式注射器市場限制因素

全球預填充式注射器市場面臨許多挑戰，主要源自於其嚴苛的生產流程。與傳統注射器不同，預填充式注射器需要完善的品質保證系統和嚴格的監管標準，以確保無菌性、精確劑量和病人安全。此外，不同地區監管準則的差異可能會延長核准時間，並增加製造商的生產成本。這些因素可能阻礙市場成長，限制產品可近性，為該領域致力於提供安全有效醫療解決方案的企業設置了重大障礙。

全球預填充式注射器市場趨勢

隨著製藥公司日益重視包裝的安全性和耐用性，全球預填充式注射器市場正經歷著向聚合物基解決方案的顯著轉變。儘管玻璃因其優異的化學相容性而一直是傳統上的主流選擇，但環烯烴聚合物（COP）和環烯烴共聚物（COC）的應用正日益廣泛。這些聚合物材料對於生物製藥和複雜藥物尤其具有吸引力，因為它們不僅強度高，還能降低玻璃破損帶來的污染風險。這一趨勢表明，人們越來越關注能夠增強產品完整性並滿足醫療保健行業不斷變化的需求的創新材料。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Becton, Dickinson and Company（BD）（USA）
Gerresheimer AG（Germany）
Schott AG（Germany）
Baxter International Inc.（USA）
Cardinal Health, Inc.（USA）
Terumo Corporation（Japan）
West Pharmaceutical Services, Inc.（USA）
Nipro Corporation（Japan）
Ompi（Italy）
SGD Pharma（France）
Stevanato Group（Italy）
Medtronic plc（Ireland）
Fresenius Kabi AG（Germany）
Ypsomed Holding AG（Switzerland）
ARaymondlife SAS（France）
Credence MedSystems, Inc.（USA）
Nemera（France）
Taisei Kako Co., Ltd.（Japan）
Weigao Group（China）
Braun Melsungen AG（Germany）

結論與建議

簡介目錄

Product Code: SQSG35B2013

Global Prefilled Syringes Market size was valued at USD 7.52 Billion in 2024 and is poised to grow from USD 8.32 Billion in 2025 to USD 18.62 Billion by 2033, growing at a CAGR of 10.6% during the forecast period (2026-2033).

The global market for pre-filled syringes is experiencing rapid growth as the pharmaceutical sector seeks efficient and user-friendly medication delivery solutions. With an increasing emphasis on self-care, the demand for pre-filled syringes is anticipated to rise significantly due to their convenience and ease of use, particularly in administering contraceptives and managing chronic conditions. The growing prevalence of diabetes and arthritis, coupled with the expansion of biosimilars, further fuels market momentum in developed markets. Additionally, the high incidence of conditions like asthma highlights the need for accessible treatment options. As healthcare consumers continue to prioritize self-administration and safety, pre-filled syringes are poised to capture a larger share of the medication delivery landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Prefilled Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Prefilled Syringes Market Segments Analysis

Global Prefilled Syringes Market is segmented by Type, Material, Application, Distribution Channel and region. Based on Type, the market is segmented into Disposable and Reusable. Based on Material, the market is segmented into Glass and Plastic. Based on Application, the market is segmented into Vaccines and immunizations, Anaphylaxis, Rheumatoid Arthritis, Diabetes, Autoimmune diseases, Oncology and Others. Based on Distribution Channel, the market is segmented into Hospitals, Mail Order Pharmacies and Ambulatory Surgery Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Prefilled Syringes Market

The rising prevalence of chronic conditions, including diabetes and rheumatoid arthritis, has significantly heightened the need for vaccines, predominantly delivered via injections. This surge in demand for injectable solutions has directly contributed to the increasing popularity of prefilled syringes. These syringes offer several advantages, such as enhanced safety through controlled packaging that lowers contamination risks and minimizes dosing errors, establishing them as a preferred choice for administering vaccines and therapeutics. Consequently, this growing reliance on efficient delivery systems is propelling the expansion of the market for prefilled syringes.

Restraints in the Global Prefilled Syringes Market

The Global Prefilled Syringes market faces several challenges stemming from the stringent manufacturing processes required for these products. Unlike traditional syringes, pre-filled syringes necessitate robust quality assurance systems and compliance with rigorous regulatory standards to guarantee sterility, precise dosing, and overall patient safety. Furthermore, the need for adherence to varying regulatory guidelines across different regions can result in extended approval timelines and elevated production costs for manufacturers. These factors may hinder market growth and limit accessibility, presenting significant hurdles for companies operating within this sector while striving to deliver safe and effective medical solutions.

Market Trends of the Global Prefilled Syringes Market

The Global Prefilled Syringes market is experiencing a notable shift towards polymer-based solutions, as pharmaceutical companies increasingly prioritize safety and durability in their packaging options. Traditionally dominated by glass, which offers excellent chemical compatibility, the market is now witnessing a rise in the adoption of cyclic olefin polymers (COP) and cyclic olefin copolymers (COC). These polymeric materials are not only stronger but also mitigate the risk of contamination associated with glass breakage, making them particularly appealing for biologics and complex pharmaceuticals. This trend highlights a growing commitment to innovative materials that enhance product integrity and meet the evolving demands of the healthcare sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis
Raw Material Analysis

Global Prefilled Syringes Market Size by Type & CAGR (2026-2033)

Market Overview
Disposable
Reusable

Global Prefilled Syringes Market Size by Material & CAGR (2026-2033)

Market Overview
Glass
Plastic

Global Prefilled Syringes Market Size by Application & CAGR (2026-2033)

Market Overview
Vaccines and immunizations
Anaphylaxis
Rheumatoid Arthritis
Diabetes
Autoimmune diseases
Oncology
Others

Global Prefilled Syringes Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Hospitals
Mail Order Pharmacies
Ambulatory Surgery Centers

Global Prefilled Syringes Market Size & CAGR (2026-2033)

North America (Type, Material, Application, Distribution Channel)
- US
- Canada
Europe (Type, Material, Application, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Material, Application, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Material, Application, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Material, Application, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Schott AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ompi (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGD Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stevanato Group (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Kabi AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ARaymondlife SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Credence MedSystems, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nemera (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Taisei Kako Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Weigao Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments